Periprocedural Outcomes of Transcatheter Mitral Valve Implantation Using a Tethered Device in a Post-market Follow-up Study

Lenard Conradi,Anna Sonia Petronio,Hendrik Ruge,Louis Labrousse,Thomas Walther,Oliver Reuthebuch,Fabien Praz,Andreas Zierer,Jörg Kempfert,Peyman Sardari Nia,Sabine Bleiziffer,Gry Dahle, G. Lutter,Nicolas Dumonteil

Thoracic and Cardiovascular Surgeon（2023）

引用 0|浏览5

暂无评分

摘要

Background: Transapical transcatheter mitral valve implantation (TMVI) provides treatment for severely ill patients with symptomatic mitral regurgitation (MR) deemed poor candidates for conventional surgery. A prospective, multi-center, single-arm, post-market follow-up (PMCF) study is enrolling to confirm safety and efficacy of a tethered transapical (TA) transcatheter heart valve (THV) in patients with severe symptomatic MR at high risk for surgery.

查看译文

关键词

transcatheter mitral valve implantation,tethered device,post-market

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要